Kesimpta is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS ...

Novartis presented positive study data at the sixth annual Americas Committee for Treatment and Research in Multiple Sclerosis Forum from nurses and patients using its Kesimpta auto-injector pen for ...

Kesimpta (ofatumumab) is a subcutaneous injection for adults with relapsing forms of multiple sclerosis. Follow the instructions here to self-inject safely. It’s important to switch injection sites ...

Kesimpta is a biologic drug, which means it’s made from parts of living organisms. It contains the active ingredient ofatumumab. Kesimpta belongs to a group of drugs called monoclonal antibodies. It ...

Novartis AG won FDA clearance for the anti-CD20 monoclonal antibody Kesimpta (ofatumumab) in relapsing forms of multiple sclerosis (MS) in adults, with a label that includes clinically isolated ...

Kesimpta is a brand-name subcutaneous injection prescribed for certain forms of multiple sclerosis (MS). Kesimpta begins working right away, but it may take some time for you to notice relief in your ...

Kesimpta can cause injection site reactions, headache, back pain, and other side effects. Kesimpta reduces immune system activity, which increases your risk of getting sick more easily than usual.

Novartis AG won FDA clearance for the anti-CD20 monoclonal antibody Kesimpta (ofatumumab) in relapsing forms of multiple sclerosis (MS) in adults, with a label that includes clinically isolated ...